SCHEMBL2176734

SCHEMBL2176734

CNc1nccc(-c2cc(NC(=O)CN3CCN(c4c(Cl)cncc4Cl)CC3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.43
MAPT P10636 5/20 0.42
TSHR P16473 3/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 4/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TDP1 Q9NUW8 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
GAA P10253 2/20 0.39
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HIF1A Q16665 1/20 0.38
GSK3B P49841 1/20 0.38
DYRK1A Q13627 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179634 0.88 TSHR (0.46) MAPTTSHRUSP2ALDH1A1LMNA
SCHEMBL2180337 0.87 KDM4E (0.43) MAPTTSHRUSP2ALDH1A1LMNA
SCHEMBL2179413 0.87 MAPT (0.41) MAPTTSHRUSP2ALDH1A1LMNA
SCHEMBL2179412 0.86 TSHR (0.46) MAPTTSHRUSP2ALDH1A1LMNA
SCHEMBL2178573 0.85 TP53 (0.45) MAPTALDH1A1LMNASMN1; SMN2TDP1
SCHEMBL2184977 0.85 KDR (0.42) MAPTTSHRALDH1A1LMNATDP1
SCHEMBL2180443 0.85 ALDH1A1 (0.54) MAPTTSHRUSP2ALDH1A1LMNA
SCHEMBL2180704 0.85 ATM (0.46) MAPTALDH1A1LMNASMN1; SMN2TDP1
SCHEMBL2179087 0.85 KMT2A (0.42) MAPTTSHRUSP2ALDH1A1LMNA
SCHEMBL2180895 0.85 KCNA5 (0.43) MAPTALDH1A1LMNASMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP AURKA 876/4885MAPT 2185/4885TSHR 4282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.